Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 4,675 | 4,167 | 254,953 | 0 | 0 |
| Gross Profit | 4,675 | 4,167 | 254,953 | N/A | N/A |
| Operating Expenses | 46,128 | 42,960 | 48,644 | 36,951 | 38,326 |
| Operating Income | -41,453 | -38,793 | 206,309 | 23,049 | -38,326 |
| Other Income | 7,823 | 7,501 | 4,357 | 4,286 | 4,221 |
| Pre-tax Income | -33,630 | -31,292 | 210,666 | 27,335 | -34,105 |
| Income Tax | -420 | -676 | 3,326 | N/A | N/A |
| Net Income Continuous | -33,210 | -30,616 | 207,340 | 27,335 | -34,105 |
| Net Income | $-33,210 | $-30,616 | $207,340 | $27,335 | $-34,105 |
| EPS Basic Total Ops | -0.54 | -0.50 | 3.41 | 0.54 | -0.58 |
| EPS Basic Continuous Ops | -0.54 | -0.50 | 3.41 | 0.53 | -0.58 |
| EPS Diluted Total Ops | -0.54 | -0.50 | 3.26 | 0.54 | -0.58 |
| EPS Diluted Continuous Ops | -0.54 | -0.50 | 3.26 | 0.53 | -0.58 |
| EPS Diluted Before Non-Recurring Items | -0.54 | -0.50 | 3.26 | N/A | N/A |
| EBITDA(a) | $-42,409 | $-40,798 | $205,514 | $-37,467 | $-38,505 |